1 St Source Bank Abbott Laboratories Transaction History

1 St Source Bank

$1.69 Billion
Q1 2025

A detailed history of 1 St Source Bank transactions in Abbott Laboratories stock. As of the latest transaction made, 1 St Source Bank holds 38,846 shares of ABT stock, worth $5.19 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

38,846

Previous 39,021 0.45%

Holding current value

$5.19 Million

Previous $4.41 Million 16.75%

% of portfolio

0.3%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$111.1 - $140.22 $19,442 - $24,538	-175 Reduced 0.45%	38,846 $5.15 Million
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $30,892 - $32,951	-276 Reduced 0.7%	39,021 $4.41 Million
Q3 2024 Dec 11, 2024	SELL	$100.07 - $118.13 $153,407 - $181,093	-1,533 Reduced 3.75%	39,297 $4.48 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $73,633 - $82,193	-731 Reduced 1.76%	40,830 $4.24 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $85,535 - $94,469	-781 Reduced 1.84%	41,561 $4.72 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $35,444 - $43,387	393 Added 0.94%	42,342 $4.66 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $28,085 - $33,698	-294 Reduced 0.7%	41,949 $4.06 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $70,344 - $78,378	-698 Reduced 1.63%	42,243 $4.61 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $25,861 - $30,440	-267 Reduced 0.62%	42,941 $4.35 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $4,753 - $5,576	50 Added 0.12%	43,208 $4.74 Million
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $5,418 - $6,273	56 Added 0.13%	43,158 $4.18 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $23,169 - $28,004	-227 Reduced 0.52%	43,102 $4.68 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $105,924 - $129,168	929 Added 2.19%	43,329 $5.13 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $557,894 - $683,110	4,829 Added 12.85%	42,400 $5.97 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $26,248 - $29,038	-225 Reduced 0.6%	37,571 $4.44 Million
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $151,597 - $178,451	-1,433 Reduced 3.65%	37,796 $4.38 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $53,222 - $62,704	-489 Reduced 1.23%	39,229 $4.7 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $134,505 - $146,572	-1,281 Reduced 3.12%	39,718 $4.35 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $247,977 - $301,150	-2,706 Reduced 6.19%	40,999 $4.46 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $19,372 - $24,794	253 Added 0.58%	43,705 $4 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $99,506 - $145,506	-1,584 Reduced 3.52%	43,452 $3.43 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $122,632 - $136,518	-1,562 Reduced 3.35%	45,036 $3.91 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $109,992 - $119,266	-1,344 Reduced 2.8%	46,598 $3.9 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $51,307 - $59,840	-704 Reduced 1.45%	47,942 $4.03 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $29,401 - $35,546	444 Added 0.92%	48,646 $3.89 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $136,692 - $154,852	-2,085 Reduced 4.15%	48,202 $3.49 Million
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $38,188 - $46,070	-628 Reduced 1.23%	50,287 $3.69 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $71,962 - $79,425	-1,250 Reduced 2.4%	50,915 $3.11 Million
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $49,236 - $55,667	875 Added 1.71%	52,165 $3.13 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $24,853 - $26,608	463 Added 0.91%	51,290 $2.93 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $2.44 Million - $2.73 Million	50,827	50,827 $2.71 Million

Others Institutions Holding ABT

# of Institutions

3,542

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

News

Stay updated on 1 St Source Bank with notifications on news.

Account